Compound Report Overview
Compound Name:
NORGESTREL
Compound Identifier:
700591
Mol Structure 2D:
700591
Molecular Weight:
312
Formula:
C21 H28 O2
Development Status:
US FDA Approved
SMILES:
CCC12CCC3C(CCC4=CC(=O)CCC34)C2CCC1(O)C#C
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| NORGESTREL | 129 | GABAA, Benzodiazepine, Central | View |
| NORGESTREL | 641 | CYP450-2C19 Inhibition | View |
| NORGESTREL | 216 | Sodium Channel, Site 2 | View |
| NORGESTREL | 212 | Serotonin Transporter | View |
| NORGESTREL | 642 | CYP450-2C9 Inhibition | View |
| NORGESTREL | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| NORGESTREL | 638 | Testosterone | View |
| NORGESTREL | 193 | Progesterone | View |
| NORGESTREL | 137 | Glucocorticoid | View |
| NORGESTREL | 635 | Protein Tyrosine Kinase, Fyn | View |
| NORGESTREL | 125 | Estrogen ERalpha | View |